Hydrazino-type radionuclide chelators having an N.sub.3 S configuration
US5659041A · kind A · utility
61Cited by
20References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 1994 |
| Grant date | Aug 19, 1997 |
| Priority date | — |
| Expiry date | Sep 2, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Radionuclide chelating compounds are provided for conjugation to targeting molecules such as proteins, peptides or antibodies. The resulting labeled targeting molecules may be used in diagnosis and therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.